Federal health officials have approved a meningitis vaccine previously unavailable in the U.S. to contain an outbreak at Princeton University. Bexsero, a vaccine approved in Australia and Europe, fights off strain B of the disease. Several students at Princeton have been diagnosed with the strain.
FDA approves meningitis vaccine for Princeton outbreak
Letter
to the
Editor
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.
Recommended for You
Sponsored Content